Q4 & FY22 Highlights
•
.
•
Our Evolution
1949 - 2005
2005-2010
Foundation
1949: Founded by Dr.
Major S. K. Lal
1995: Company
incorporated as Dr. Lal
PathLabs Private Ltd.
2000: Three clinical labs
receive NABL¹
accreditation
2001: Received ISO
9001:2008 certification
2002: Received
'International
Accreditation' from CAP²
Building
capabilities for
scale up
2005: onwards:
Investment by
2010 - 2015
Strong position in
North India, building
network in other
geographies
Investment by TA
Associates
Clinical laboratories
expansion in North
region
WestBridge Capital
•
Growing the business in
East region
.
2008: Acquisition of
•
Paliwal Medicare Private
•
Limited and Paliwal
Entry into the South and
West regions
Diagnostics Private
Limited
2010: National Reference
Lab set up in Delhi
Multiple acquisitions to
scale network
Successful IPO listing in
Dec 2015
2015-2020
Higher contribution from
Rest of India,
Commissioned state
of the art Kolkata
Reference Lab
Higher contribution from
Rest of India business &
focus on bundled test
program "Swasthfit"
Successful commissioning
of Regional Reference Lab
at Kolkata in 2018
Inorganic growth through
acquisition of laboratories
in Western & Southern
India
•
2020 onwards
Pan India Player -
Acquired Suburban,
Building South
Ecosystem
First to set-up RT-PCR
testing network in 2020
Completed acquisition of
Suburban Diagnostics in
2021
· Expanded South
ecosystem through
Bengaluru Reference Lab
and network of Hub &
Satellite labs
Established hub labs in
North region
Spearheading investments
in Digital and InfoSec
1.
Classification: Restricted 2.
NABL: National Accreditation Board for Calibration and Testing Laboratories.
CAP: College of American Pathologists.
6
Dr Lal PathLabsView entire presentation